Solvemed Group sp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-09-15
Share capital
1,502,300.00 PLN
Activity description

Solvemed Group offers the PuRe™ Pupillometer, a smartphone-based FDA medical device for objective pupil size and reactivity testing without additional hardware. It provides testing unaffected by ambient light, requires no disposables, and can integrate with hospital electronic medical record systems.

Registered address
ul. Święty Marcin 29/8, 61-806 Poznań, Poland
Email
Electronic delivery address
AE:PL-86182-87691-TGWIR-28

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 109 days for 2020).

  • 202509/07/2026
  • 202426/06/2025
  • 202302/07/2024
  • 202210/07/2023
  • 202105/10/2022
  • 202001/02/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 66%
Top 74%
City · Poznań8,840 / 11,757
Top 75%
Voivodeship · Wielkopolskie24,627 / 30,968
Top 80%
Country · Poland234,297 / 298,026
Top 79%

Results vs industry

Revenue
This companyUSD 36.01kMedianUSD 154.14kAverageUSD 4.79m
Net profit
This companyUSD -1.28mMedianUSD -276.14AverageUSD 308.69k
Operating costs
This companyUSD 1.28mMedianUSD 188.95kAverageUSD 4.61m
Assets
This companyUSD 471.99kMedianUSD 283.11kAverageUSD 8.34m

Offer

Websites

  • solvemed.aiSolvemed.ai ― Objective pupil reactivity testing. Now in your smartphone.
    WebflowGoogle AnalyticsGoogle Tag ManagerCloudflare

Job offers

The company lists 2 job openings on its own careers page: solvemed.ai/careers.

Position
Postdoctoral Senior Research Associate – AI, Biostatistics & Eye Biometrics
Postdoctoral senior research associate – human-computer interaction & mobile eye biometrics

Authorized Representatives

Hugo Jan Chróst age 24 – President of the Management Board
Michał Włodarski age 37 – Vice President of the Management Board

Manner of representation

If the company has a one-person management board, the sole member of the management board is authorised to represent the company independently. If the company has a management board consisting of 2 (two) or more members of the management board, the company is represented: (i) by the President of the Management Board or the Vice-President acting independently, or (ii) by 2 (two) members of the management board acting jointly, including a member of the management board acting jointly with the President or the Vice-President of the Management Board.

Ownership

OwnerSharesShare valueStake
Solvemed Holding Inc.
29,804$402,539.1799.1946%
Others
242$3,268.500.8054%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2021-04-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid for SME access to finance — risk finance aid
$1.5M
Aid for SME access to finance — risk finance aid
$448.6K
Aid in the form of risk capital
$511K

Competitors

Name
Aidmed sp. z o.o.
FREY sp. z o.o.
YOT Med sp. z o.o.
Brain Optics sp. z o.o.
Zakłady Automatyki Rotametr sp. z o.o.
Spinheadset sp. z o.o.
My Ovu sp. z o.o.
Axonometry sp. z o.o.
Smartmedics sp. z o.o.
ARCO Innowacyjne Przedsiębiorstwo Informatyki i Inżynierii sp. z o.o.

Change history

DateEvent
2025-07-25Share capital increase
2025-07-25Switch to PKD 2025
2024-11-06Share capital increase
2024-06-24Share capital increase
2023-12-18Share capital increase

FAQ

Last updated: 2026-10-07